AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Karnataka: BJP MLA used HIV positive women to honey trap rivals, probe launched

MUDA case: Karnataka HC rejects Siddaramaiah’s plea against Governor move